ユーバイオティクス市場：形態、家畜、タイプ、機能別-2025-2030年の世界予測

ユーバイオティクス市場は、2023年に93億2,000万米ドルと評価され、2024年には108億米ドルに達すると予測され、CAGR 15.99％で成長し、2030年には263億4,000万米ドルに達すると予測されています。

ユーバイオティクスは、動物栄養学の中で成長している分野であり、プロバイオティクス、プレバイオティクス、有機酸、エッセンシャルオイルなど、家畜の腸内健康と全体的な幸福を高めるように設計された製品を包含しています。ユーバイオティクスの必要性は、規制の強化や天然サプリメントに対する消費者の嗜好から、抗生物質の代替品に対する畜産業界の需要から生じています。ユーバイオティクスの主な用途は、動物の免疫システムを強化しながら栄養吸収と成長パフォーマンスを向上させ、食肉の品質と生産性を改善するための動物飼料です。最終用途には家禽、豚、牛、水産養殖が含まれ、家禽部門は消費量と生産量が多いため現在リードしています。主な市場成長要因としては、製品の安全性に関する消費者の意識の高まり、より効果的な製剤のためのバイオテクノロジーの進歩、抗生物質の使用削減を推進する規制の枠組みなどが挙げられます。オーガニックでヘルシーな食肉に対する消費者の需要が高まる中、市場セグメンテーションはこのセグメントに対応する絶好の機会となっています。こうしたチャンスを生かすため、企業はコスト効率が高く効率的な製品技術の開発に注力し、革新的なソリューションを求めて農業研究機関との共同研究に取り組むべきです。

しかし、この市場は、製品の有効性が一貫していない、動物種によって反応にばらつきがあるなどの課題に直面しており、これが普及の妨げとなっています。また、生産コストが高く、規制要件が厳しいことも制約となります。これらの課題に対処するためには、ユーバイオティクス製剤を標準化し、異なる動物種間でスケーラブルなソリューションを確保するための研究に投資することが重要です。イノベーションは、より優れた安定性と効率を実現するために、多種類の製剤や強化された送達システムに焦点を当てることができます。さらに、動物の健康パターンを評価し、ユーバイオティクス介入をカスタマイズするために人工知能とビッグデータ分析を活用することは、大きな進歩につながる可能性があります。競合市場であると同時に有望な市場であり、既存大手企業と新興新興企業が混在し、技術の進歩と科学的研究によって絶えず進化しているのが特徴です。

市場力学：急速に進化するユーバイオティクス市場の主要市場インサイトを公開

ユーバイオティクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 飼料の品質と安全性に関する意識の高まり
  • 世界の食肉消費量の増加
  • 飼料中の抗生物質使用に対する厳しい規制
• 市場抑制要因
  • 原材料の供給制限と高コスト
• 市場機会
  • 優れた製品開発のための継続的な研究開発活動
  • 動物栄養学への投資の増加
• 市場の課題
  • 家畜の疾病発生に関する懸念

ポーターの5つの力：ユーバイオティクス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ユーバイオティクス市場における外部からの影響の把握

外部マクロ環境要因は、ユーバイオティクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ユーバイオティクス市場における競合情勢の把握

ユーバイオティクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスユーバイオティクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ユーバイオティクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ユーバイオティクス市場における成功への道筋を描く

ユーバイオティクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 飼料の品質と安全性に関する意識の向上
    • 世界中で肉の消費量増加
    • 家畜飼料における抗生物質の使用に関する厳格な規制
  • 抑制要因
    • 原材料の供給が限られており、コストが高い
  • 機会
    • 優れた製品の開発に向けた継続的な研究開発活動
    • 動物栄養への投資増加
  • 課題
    • 家畜の疾病発生への懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ユーバイオティクス市場：形態別

• ドライ
• 液体

第7章 ユーバイオティクス市場家畜別

• 水生動物
• 家禽
• 反芻動物
• 豚

第8章 ユーバイオティクス市場：タイプ別

• エッセンシャルオイル
• 有機酸
  • 酢酸
  • ギ酸
  • フマル酸
  • 乳酸
  • プロピオン酸
• プレバイオティクス
  • フルクトオリゴ糖
  • ガラクトオリゴ糖
  • イヌリン
  • マンナンオリゴ糖
• プロバイオティクス
  • ビフィズス菌
  • 乳酸菌
  • ストレプトコッカス・サーモフィルス

第9章 ユーバイオティクス市場：機能別

• 免疫
• 栄養と腸の健康
• 生産性
• 収率

第10章 南北アメリカのユーバイオティクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のユーバイオティクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのユーバイオティクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• ADDCON GmbH
• Advanced BioNutrition Corp
• Alltech, Inc.
• BASF SE
• Behn Meyer Group
• Cargill Incorporated
• DuPont de Nemours, Inc.
• Kemin Industries, Inc.
• Kerry Group PLC
• Koninklijke DSM N.V.
• Lallemand, Inc.
• Lesaffre Group
• Lonza Group AG
• Novozymes A/S
• Novus International, Inc.

LIST OF FIGURES

• FIGURE 1. EUBIOTICS MARKET RESEARCH PROCESS
• FIGURE 2. EUBIOTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL EUBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL EUBIOTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL EUBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL EUBIOTICS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL EUBIOTICS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL EUBIOTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL EUBIOTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL EUBIOTICS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL EUBIOTICS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS EUBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS EUBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES EUBIOTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES EUBIOTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC EUBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC EUBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EUBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EUBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. EUBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. EUBIOTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL EUBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL EUBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL EUBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. EUBIOTICS MARKET DYNAMICS
• TABLE 7. GLOBAL EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL EUBIOTICS MARKET SIZE, BY DRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL EUBIOTICS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL EUBIOTICS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL EUBIOTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL EUBIOTICS MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL EUBIOTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL EUBIOTICS MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL EUBIOTICS MARKET SIZE, BY ACETIC ACID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL EUBIOTICS MARKET SIZE, BY FORMIC ACID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL EUBIOTICS MARKET SIZE, BY FUMARIC ACID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL EUBIOTICS MARKET SIZE, BY LACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL EUBIOTICS MARKET SIZE, BY PROPIONIC ACID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL EUBIOTICS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL EUBIOTICS MARKET SIZE, BY FRUCTO-OLIGOSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL EUBIOTICS MARKET SIZE, BY GALACTO-OLIGOSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL EUBIOTICS MARKET SIZE, BY INULIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL EUBIOTICS MARKET SIZE, BY MANNAN-OLIGOSACCHARIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL EUBIOTICS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL EUBIOTICS MARKET SIZE, BY BIFIDOBACTERIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL EUBIOTICS MARKET SIZE, BY LACTOBACILLI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL EUBIOTICS MARKET SIZE, BY STREPTOCOCCUS THERMOPHILUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL EUBIOTICS MARKET SIZE, BY IMMUNITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL EUBIOTICS MARKET SIZE, BY NUTRITION & GUT HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL EUBIOTICS MARKET SIZE, BY PRODUCTIVITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL EUBIOTICS MARKET SIZE, BY YIELD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS EUBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 62. CANADA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 63. CANADA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 64. CANADA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. CANADA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 66. CANADA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 67. CANADA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 68. CANADA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES EUBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC EUBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 99. CHINA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 100. CHINA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 101. CHINA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. CHINA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 103. CHINA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 104. CHINA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 105. CHINA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 106. INDIA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 107. INDIA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 108. INDIA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. INDIA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 110. INDIA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 111. INDIA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 112. INDIA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 118. INDONESIA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 119. INDONESIA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 125. JAPAN EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 126. JAPAN EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 131. MALAYSIA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 132. MALAYSIA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 133. MALAYSIA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 138. PHILIPPINES EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 139. PHILIPPINES EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 140. PHILIPPINES EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 145. SINGAPORE EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 146. SINGAPORE EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 147. SINGAPORE EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 152. SOUTH KOREA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 153. SOUTH KOREA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 154. SOUTH KOREA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 159. TAIWAN EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 160. TAIWAN EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 161. TAIWAN EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 166. THAILAND EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 167. THAILAND EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 168. THAILAND EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 173. VIETNAM EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 174. VIETNAM EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 175. VIETNAM EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 183. EUROPE, MIDDLE EAST & AFRICA EUBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 188. DENMARK EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 189. DENMARK EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 190. DENMARK EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 195. EGYPT EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 196. EGYPT EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 197. EGYPT EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 202. FINLAND EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 203. FINLAND EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 204. FINLAND EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 209. FRANCE EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 210. FRANCE EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 211. FRANCE EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 216. GERMANY EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 217. GERMANY EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 218. GERMANY EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 223. ISRAEL EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 224. ISRAEL EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 225. ISRAEL EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 226. ITALY EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 227. ITALY EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 228. ITALY EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 229. ITALY EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 230. ITALY EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 231. ITALY EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 232. ITALY EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 237. NETHERLANDS EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 238. NETHERLANDS EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 239. NETHERLANDS EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 244. NIGERIA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 245. NIGERIA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 246. NIGERIA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 251. NORWAY EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 252. NORWAY EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 253. NORWAY EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 254. POLAND EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 255. POLAND EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 256. POLAND EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 257. POLAND EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 258. POLAND EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 259. POLAND EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 260. POLAND EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 261. QATAR EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 262. QATAR EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 263. QATAR EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 264. QATAR EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 265. QATAR EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 266. QATAR EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 267. QATAR EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 272. RUSSIA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 273. RUSSIA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 274. RUSSIA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 279. SAUDI ARABIA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 280. SAUDI ARABIA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 281. SAUDI ARABIA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 286. SOUTH AFRICA EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 287. SOUTH AFRICA EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 288. SOUTH AFRICA EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 293. SPAIN EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 294. SPAIN EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 295. SPAIN EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 300. SWEDEN EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 301. SWEDEN EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 302. SWEDEN EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 307. SWITZERLAND EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 308. SWITZERLAND EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 309. SWITZERLAND EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 313. TURKEY EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 314. TURKEY EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 315. TURKEY EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 316. TURKEY EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 320. UNITED ARAB EMIRATES EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 321. UNITED ARAB EMIRATES EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 322. UNITED ARAB EMIRATES EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 323. UNITED ARAB EMIRATES EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM EUBIOTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 325. UNITED KINGDOM EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 326. UNITED KINGDOM EUBIOTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 327. UNITED KINGDOM EUBIOTICS MARKET SIZE, BY ORGANIC ACIDS, 2018-2030 (USD MILLION)
• TABLE 328. UNITED KINGDOM EUBIOTICS MARKET SIZE, BY PREBIOTICS, 2018-2030 (USD MILLION)
• TABLE 329. UNITED KINGDOM EUBIOTICS MARKET SIZE, BY PROBIOTICS, 2018-2030 (USD MILLION)
• TABLE 330. UNITED KINGDOM EUBIOTICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 331. EUBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 332. EUBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Eubiotics Market was valued at USD 9.32 billion in 2023, expected to reach USD 10.80 billion in 2024, and is projected to grow at a CAGR of 15.99%, to USD 26.34 billion by 2030.

Eubiotics, a growing sector within animal nutrition, encompasses products like probiotics, prebiotics, organic acids, and essential oils designed to enhance the gut health and overall well-being of livestock. The necessity for eubiotics arises from the livestock industry's demand for antibiotic alternatives due to increased regulations and consumer preference for natural supplements. The primary application of eubiotics is in animal feed to improve nutrient absorption and growth performance while bolstering animals' immune systems, thus improving meat quality and productivity. End-use scope includes poultry, swine, cattle, and aquaculture, with the poultry sector currently leading due to high consumption and production rates. Key market growth factors include rising consumer awareness about product safety, advancements in biotechnology for more effective formulations, and regulatory frameworks pushing toward reduced antibiotic use. As consumer demand for organic and healthy meat rises, the eubiotics market has a golden opportunity to cater to this segment. To capitalize on these opportunities, companies should focus on developing cost-effective and efficient product technologies and engage in collaborative research with agricultural institutes for innovative solutions.

However, the market faces challenges such as inconsistent product efficacy and variability in response across different animal species, which can hinder widespread adoption. The high cost of production and stringent regulatory requirements also pose limitations. To address these challenges, it is important to invest in research to standardize eubiotic formulations and ensure scalable solutions across different animal species. Innovations could focus on multispecies formulations and enhanced delivery systems for better stability and efficiency. Furthermore, utilizing artificial intelligence and big data analytics to assess animal health patterns and customize eubiotic interventions could lead to significant advancements. The eubiotics market is competitive yet promising, characterized by a mix of large established firms and emerging startups, continually evolving with technological advancement and scientific research.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Eubiotics Market

The Eubiotics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing awareness about feed quality and safety
  • Rising meat consumption across the globe
  • Strict regulations for the usage of antibiotics in animal feeding
• Market Restraints
  • Limited supply of raw materials and high cost
• Market Opportunities
  • Ongoing R&D activities for the development of superior products
  • Growing investment in animal nutrition
• Market Challenges
  • Concern regarding disease outbreak in livestock

Porter's Five Forces: A Strategic Tool for Navigating the Eubiotics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Eubiotics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Eubiotics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Eubiotics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Eubiotics Market

A detailed market share analysis in the Eubiotics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Eubiotics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Eubiotics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Eubiotics Market

A strategic analysis of the Eubiotics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Eubiotics Market, highlighting leading vendors and their innovative profiles. These include ADDCON GmbH, Advanced BioNutrition Corp, Alltech, Inc., BASF SE, Behn Meyer Group, Cargill Incorporated, DuPont de Nemours, Inc., Kemin Industries, Inc., Kerry Group PLC, Koninklijke DSM N.V., Lallemand, Inc., Lesaffre Group, Lonza Group AG, Novozymes A/S, and Novus International, Inc..

Market Segmentation & Coverage

This research report categorizes the Eubiotics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Form, market is studied across Dry and Liquid.
• Based on Livestock, market is studied across Aquatic Animals, Poultry, Ruminants, and Swine.
• Based on Type, market is studied across Essential Oils, Organic Acids, Prebiotics, and Probiotics. The Organic Acids is further studied across Acetic Acid, Formic Acid, Fumaric Acid, Lactic Acid, and Propionic Acid. The Prebiotics is further studied across Fructo-Oligosaccharides, Galacto-Oligosaccharides, Inulin, and Mannan-Oligosaccharide. The Probiotics is further studied across Bifidobacteria, Lactobacilli, and Streptococcus Thermophilus.
• Based on Function, market is studied across Immunity, Nutrition & Gut Health, Productivity, and Yield.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing awareness about feed quality and safety
    • 5.1.1.2. Rising meat consumption across the globe
    • 5.1.1.3. Strict regulations for the usage of antibiotics in animal feeding
  • 5.1.2. Restraints
    • 5.1.2.1. Limited supply of raw materials and high cost
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing R&D activities for the development of superior products
    • 5.1.3.2. Growing investment in animal nutrition
  • 5.1.4. Challenges
    • 5.1.4.1. Concern regarding disease outbreak in livestock
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Eubiotics Market, by Form

• 6.1. Introduction
• 6.2. Dry
• 6.3. Liquid

7. Eubiotics Market, by Livestock

• 7.1. Introduction
• 7.2. Aquatic Animals
• 7.3. Poultry
• 7.4. Ruminants
• 7.5. Swine

8. Eubiotics Market, by Type

• 8.1. Introduction
• 8.2. Essential Oils
• 8.3. Organic Acids
  • 8.3.1. Acetic Acid
  • 8.3.2. Formic Acid
  • 8.3.3. Fumaric Acid
  • 8.3.4. Lactic Acid
  • 8.3.5. Propionic Acid
• 8.4. Prebiotics
  • 8.4.1. Fructo-Oligosaccharides
  • 8.4.2. Galacto-Oligosaccharides
  • 8.4.3. Inulin
  • 8.4.4. Mannan-Oligosaccharide
• 8.5. Probiotics
  • 8.5.1. Bifidobacteria
  • 8.5.2. Lactobacilli
  • 8.5.3. Streptococcus Thermophilus

9. Eubiotics Market, by Function

• 9.1. Introduction
• 9.2. Immunity
• 9.3. Nutrition & Gut Health
• 9.4. Productivity
• 9.5. Yield

10. Americas Eubiotics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Eubiotics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Eubiotics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ADDCON GmbH
• 2. Advanced BioNutrition Corp
• 3. Alltech, Inc.
• 4. BASF SE
• 5. Behn Meyer Group
• 6. Cargill Incorporated
• 7. DuPont de Nemours, Inc.
• 8. Kemin Industries, Inc.
• 9. Kerry Group PLC
• 10. Koninklijke DSM N.V.
• 11. Lallemand, Inc.
• 12. Lesaffre Group
• 13. Lonza Group AG
• 14. Novozymes A/S
• 15. Novus International, Inc.